Yahoo Web Search

Search results

    • Q1 2024 Organon & Co Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 2 hours ago

      For the full year, we expect growth to be driven by NEXPLANON's leadership in contraception, the benefits of our pricing strategy, including list price in the U.S. and management ...

    • Stephanie Sober

      Stephanie Sober

      Time Magazine· 17 hours ago

      Dr. Stephanie Sober, medical liaison at Perrigo, which makes Opill, co-led the study that her company submitted to request the switch. The process began...